Melanoma Research Foundation
- Assets
- $7.3m
- Revenue
- $7.8m
- Investments
- $0.0
- Employees
- 22
- Location
- Washington, DC
- Founding
- 11/1996
- Data as of
- 03/2024
- EIN
- 76-0514428
Organization Overview
Melanoma Research Foundation is located in Washington, DC. The organization was established in 1996. According to its NTEE Classification (Z99) the organization is classified as: Unknown, under the broad grouping of Unknown and related organizations. As of 03/2024, Melanoma Research Foundation employed 22 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Melanoma Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 03/2024, Melanoma Research Foundation generated $7.8m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 4.2% each year. All expenses for the organization totaled $6.7m during the year ending 03/2024. While expenses have increased by 1.9% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Melanoma Research Foundation has awarded 83 individual grants totaling $11,165,754. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2024
Describe the Organization's Mission:
Part 3 - Line 1
TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING TO AND ADVOCATING FOR THE MELANOMA COMMUNITY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE MRF IS COMMITTED TO ADVANCING A BROAD SCIENTIFIC AGENDA ACROSS THE DISCIPLINES OF PREVENTION, DIAGNOSIS, AND TREATMENT. ALTHOUGH THE MRF HAS ACHIEVED A NUMBER OF IMPORTANT SCIENTIFIC MILESTONES, MUCH MORE WORK REMAINS TO BE DONE. TO THIS END, THE MRF FUNDS A SPECTRUM OF RESEARCH GRANTS, SCIENTIFIC INITIATIVES, AND PROGRAMS FOR CUTANEOUS MELANOMA AND RARER MELANOMA SUBTYPES (E.G. OCULAR, PEDIATRIC, ACRAL AND MUCOSAL MELANOMA). ITS RESEARCH GRANT PROGRAM IS A COMPETITIVE, PEER-REVIEWED RESEARCH GRANT PROGRAM FOR INVESTIGATOR-INITIATED RESEARCH HAS BEEN IN EXISTENCE SINCE 1998. MRF-SUPPORTED RESEARCH IS OPEN TO MEDICAL STUDENTS THROUGH SENIOR INVESTIGATIVE TEAMS AND ENCOMPASS.
THE MRF'S ADVOCACY PROGRAM IS A PLATFORM FOR THOSE AFFECTED BY MELANOMA TO SHARE THEIR VOICE AND TRANSFORM MELANOMA CARE. PATIENTS, CAREGIVERS, SURVIVORS, HEALTHCARE PROFESSIONALS AND PARTNERS ALL PLAY A CRITICAL ROLE IN THE ADVANCEMENT OF BETTER OUTCOMES FOR THE OVER ONE MILLION AMERICANS LIVING WITH MELANOMA AND THEIR LOVED ONES.
THE MRF HAS A ROBUST EDUCATION PROGRAM AIMED AT EDUCATING PATIENTS AND PHYSICIANS ABOUT THE PREVENTION, DIAGNOSIS, AND TREATMENT OF MELANOMA, AS WELL AS INCREASING OVERALL AWARENESS OF THE DISEASE. IN ADDITION, THE MRF MAINTAINS A LARGE PORTFOLIO OF FREE EDUCATIONAL MATERIALS THAT CAN BE USED AT FUNDRAISERS, DOCTORS' OFFICES, SCHOOLS, AND HEALTH FAIRS.PART OF THE MRF'S EDUCATIONAL OFFERINGS ALSO INCLUDE PATIENT-FOCUSED EDUCATIONAL SYMPOSIA THROUGHOUT THE U.S., IMPACTING NEARLY 1,500 PEOPLE TOUCHED BY MELANOMA. THESE SYMPOSIA PROVIDE MELANOMA PATIENTS AND THE PEOPLE WHO SUPPORT THEM THE OPPORTUNITY TO LEARN FROM LEADING MELANOMA EXPERTS ON THE MOST CURRENT PREVENTION, DIAGNOSIS, TREATMENT, AND RESEARCH INFORMATION.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Kyleigh Lipira CEO | OfficerTrustee | 40 | $336,485 |
James Merrick Chief Communications Officer | 40 | $178,462 | |
Jessica Allison Director Of Corporate Relations | 40 | $114,686 | |
Douglas Brodman Chair | OfficerTrustee | 2 | $0 |
Alison Martin MD Vice Chair - Until 01/2024 | OfficerTrustee | 2 | $0 |
Thomas Westdyk Secretary And Governance - As Of 01/2024 | OfficerTrustee | 2 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Cliftonlarsonallen Llp Outsourced Accounting Services | 3/30/24 | $260,581 |
Cps 5 Llc Dbs Cps Events At The Plaza Gala Venue | 3/30/24 | $136,444 |
Blackbaud Donor Database & Accounting Support | 3/30/24 | $438,950 |
The Emmes Company Llc Clinical Research Services | 3/30/24 | $117,443 |
Stan Adler Associates Graphic Design And Production Services | 3/30/24 | $131,494 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $2,724,608 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $5,579,028 |
| Noncash contributions included in lines 1a–1f | $1,129,444 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $8,303,636 |
| Total Program Service Revenue | $0 |
| Investment income | $69,826 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $173,151 |
| Net Income from Fundraising Events | -$772,051 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $7,774,562 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,804,954 |
| Grants and other assistance to domestic individuals. | $45,000 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $259,561 |
| Compensation of current officers, directors, key employees. | $186,884 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,554,847 |
| Pension plan accruals and contributions | $25,050 |
| Other employee benefits | $140,817 |
| Payroll taxes | $132,100 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $3,408 |
| Fees for services: Accounting | $304,397 |
| Fees for services: Lobbying | $73,222 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $7,007 |
| Fees for services: Other | $927,937 |
| Advertising and promotion | $74,102 |
| Office expenses | $239,301 |
| Information technology | $415,238 |
| Royalties | $0 |
| Occupancy | $201,096 |
| Travel | $243,364 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $86,340 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $51,717 |
| Insurance | $15,698 |
| All other expenses | $0 |
| Total functional expenses | $6,697,219 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $22,223 |
| Savings and temporary cash investments | $71,038 |
| Pledges and grants receivable | $3,900,412 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $269,601 |
| Net Land, buildings, and equipment | $214,562 |
| Investments—publicly traded securities | $1,706,411 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $1,086,625 |
| Total assets | $7,270,872 |
| Accounts payable and accrued expenses | $416,597 |
| Grants payable | $1,007,941 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $1,397,433 |
| Total liabilities | $2,821,971 |
| Net assets without donor restrictions | $1,009,170 |
| Net assets with donor restrictions | $3,439,731 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $7,270,872 |
Grants Awarded
Over the last fiscal year, Melanoma Research Foundation has awarded $1,810,000 in support to 10 organizations.
| Grant Recipient | Amount |
|---|---|
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PURPOSE: TO SUPPORT MELANOMA CANCER RESEARCH | $300,000 |
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC PURPOSE: TO SUPPORT MELANOMA CANCER RESEARCH | $250,000 |
SCHEPENS EYE RESEARCH INSTITUTE INC PURPOSE: TO SUPPORT MELANOMA CANCER RESEARCH | $250,000 |
DANA-FARBER CANCER INSTITUTE INC PURPOSE: TO SUPPORT MELANOMA CANCER RESEARCH | $200,000 |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE PURPOSE: TO SUPPORT MELANOMA CANCER RESEARCH | $200,000 |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI PURPOSE: TO SUPPORT MELANOMA CANCER RESEARCH | $200,000 |